20/20 Biolabs

(NASDAQ) AIDX

Current Price$1.03

Market Cap$12.63M

Since IPO (2026)-95%

5 YearN/A

1 YearN/A

1 Month-45%

20/20 Biolabs Financials at a Glance

Market Cap

$12.63M

Revenue (TTM)

$1.67M

Net Income (TTM)

$6.07M

EPS (TTM)

$0.00

P/E Ratio

2.62

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$1.03

Volume

9,413,828.999

Open

$1.31

Price

$1.03

Volume

9,413,828.999

Open

$1.31

Previous Close

$0.98

Daily Range

$0.90 - $1.36

52-Week Range

$0.90 - $50.00

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$1.03

Volume

9,413,828.999

Open

$1.31

Previous Close

$0.98

Daily Range

$0.90 - $1.36

52-Week Range

$0.90 - $50.00

AIDX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About 20/20 Biolabs

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Jonathan Cohen

Website

2020biolabs.com

Headquarters

Gaithersburg, MD 20877, US

AIDX Financials

Key Financial Metrics (TTM)

Gross Margin

28%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

Return on Capital

-1%

Return on Assets

-72%

Earnings Yield

38.17%

Dividend Yield

0.00%

Payout Ratio

-1.29%

Stock Overview

Market Cap

$12.63M

Shares Outstanding

10.48M

Volume

9.41M

Avg. Volume

228.30K

Financials (TTM)

Gross Profit

$604.54M

Operating Income

$3.33B

EBITDA

$3.33B

Operating Cash Flow

$1.92B

Capital Expenditure

$0.00

Free Cash Flow

$1.92B

Cash & ST Invst.

$1.03B

Total Debt

$1.28B

20/20 Biolabs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$353.38K

+5.2%

Gross Profit

$62.88K

+60.8%

Gross Margin

17.80%

N/A

Market Cap

$12.63M

N/A

Market Cap/Employee

$971.42K

N/A

Employees

N/A

Net Income

$2.12M

-23.5%

EBITDA

$1.44M

+16.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$3.60M

-9.4%

Accounts Receivable

$201.48K

-10.0%

Inventory

$104.52K

+41.8%

Long Term Debt

$429.12K

-79.2%

Short Term Debt

$189.65K

+8.9%

Return on Assets

-72.29%

N/A

Return on Invested Capital

-1.08%

N/A

Free Cash Flow

$1.29M

N/A

Operating Cash Flow

$1.29M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7491.00+0.01%

^DJIDJI

^DJIDJI$50730.23+0.01%

^IXICNASDAQ

^IXICNASDAQ$26415.97+0.00%

BTCBitcoin

BTCBitcoin$76772.00-0.01%

AAPLAAPL

AAPLAAPL$309.38+0.01%

AMZNAMZN

AMZNAMZN$267.98-0.00%

GOOGGOOG

GOOGGOOG$380.66-0.01%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

FUTUFutu

FUTUFutu$89.76-0.28%

Questions About AIDX

What is the current price of 20/20 Biolabs?

20/20 Biolabs is trading at $0.98 per share.

What is the 52-week range for 20/20 Biolabs?

Over the past 52 weeks, 20/20 Biolabs has traded between $0.90 and $50.00.

How much debt does 20/20 Biolabs have?

As of the most recent reporting period, 20/20 Biolabs reported total debt of $925,487.

How much cash does 20/20 Biolabs have on hand?

20/20 Biolabs reported $4.22M in cash and cash equivalents in its most recent financial results.

What is 20/20 Biolabs’s dividend yield?

20/20 Biolabs does not currently have a dividend yield.

20/20 Biolabs

20/20 Biolabs Financials at a Glance

AIDX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About 20/20 Biolabs

AIDX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

20/20 Biolabs Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AIDX

What is the current price of 20/20 Biolabs?

What is the 52-week range for 20/20 Biolabs?

How much debt does 20/20 Biolabs have?

How much cash does 20/20 Biolabs have on hand?

What is 20/20 Biolabs’s dividend yield?

Premium Investing Services